Association of exonic variants of Klotho with metabolic syndrome in Asian Indians

Clinica Chimica Acta

Volumn 412, Issue 11-12, 2011, Pages 1116-1121

  Majumdar, Vijaya ^a   Christopher, Rita ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Asian Indians; Insulin resistance; Klotho; Klotho C1818T; Klotho KL VS; Metabolic syndrome

Indexed keywords

GLUCOSE; KLOTHO PROTEIN;

ADULT; ARTICLE; ASIAN; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LINKAGE ANALYSIS; MALE; METABOLIC SYNDROME X; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; EXONS; FEMALE; GENETIC VARIATION; GENOTYPE; GLUCURONIDASE; HUMANS; INDIA; INSULIN RESISTANCE; LINKAGE DISEQUILIBRIUM; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 79955015611     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2011.02.034     Document Type: Article

References (34)

1. Kuro-o M., Matsumura Y., Aizawa H., et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997, 390:45-51.
2. Yamagishi T., Saito Y., Nakamura T., et al. Troglitazone improves endothelial function and augments renal klotho mRNA expression in Otsuka Long-Evans Tokushima Fatty (OLETF) rats with multiple atherogenic risk factors. Hypertens Res 2001, 24:705-709.
3. Saito Y., Nakamura T., Ohyama Y., et al. In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem Biophys Res Commun 2000, 276:767-772.
4. Maekawa Y., Ishikawa K., Yasuda O., et al. Klotho suppresses TNF-alpha-induced expression of adhesion molecules in the endothelium and attenuates NF-kappaB activation. Endocrine 2009, 35:341-346.
5. Arking D.E., Krebsova A., Macek M., et al. Association of human aging with a functional variant of klotho. Proc Natl Acad Sci USA 2002, 99:856-861.
6. Arking D.E., Becker D.M., Yanek L.R., et al. KLOTHO allele status and the risk of early-onset occult coronary artery disease. Am J Hum Genet 2003, 72:1154-1161.
7. Arking D.E., Atzmon G., Arking A., Barzilai N., Dietz H.C. Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circ Res 2005, 96:412-418.
8. Majumdar V., Nagaraja D., Christopher R. Association of the functional KL-VS variant of Klotho gene with early-onset ischemic stroke. Biochem Biophys Res Commun 2010, 403:412-416.
9. Kurosu H., Yamamoto M., Clark J.D., et al. Suppression of aging in mice by the hormone Klotho. Science 2005, 309:1829-1833.
10. Unger R.H. Klotho-induced insulin resistance: a blessing in disguise?. Nat Med 2006, 12:56-57.
11. Lorenzi O., Veyrat-Durebex C., Wollheim C.B., et al. Evidence against a direct role of klotho in insulin resistance. Pflugers Arch 2010, 459:465-473.
12. Rhee E.J., Oh K.W., Yun E.J., et al. Relationship between polymorphisms G395A in promoter and C1818T in exon 4 of the KLOTHO gene with glucose metabolism and cardiovascular risk factors in Korean Women. J Endocrinol Invest 2006, 29:613-618.
13. Shimoyama Y., Nishio K., Hamajima N., Niwa T. KLOTHO gene polymorphisms G-395A and C1818T are associated with lipid and glucose metabolism, bone mineral density and systolic blood pressure in Japanese healthy subjects. Clin Cim Acta 2009, 40:134-138.
14. Rhee E.J., Oh K.W., Lee W.Y., et al. The differential effects of age on the association of KLOTHO gene polymorphisms with coronary artery disease. Metabolism 2006, 55:1344-1351.
15. Friedewald W.T., Levy R.I., Fredrikson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
16. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
17. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third report of the national cholesterol education program expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Circulation 2002, 106:3143-3421.
18. Misra A., Vikram N.K., Gupta R., Pandey R.M., Wasir J.S., Gupta V.P. Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity. Int J Obes (Lond) 2006, 30:106-111.
19. Stern S.E., Williams K., Ferrannini E., DeFronzo R.A., Bogardus C., Stern M.P. Identification of individuals with insulin resistance using routine clinical measurements. Diabetes 2005, 54:333-339.
20. McQueen M.B., Bertram L., Rimm E.B., Blacker D., Santangelo S.L. A QTL genome scan of the metabolic syndrome and its component traits. BMC Genet 2003, 4(Suppl. 1):S96.
21. Lee Y.J., Tsai J.C. ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 2002, 25:1002-1008.
22. Dallongeville J., Helbecque N., Cottel D., Amouyel P., Meirhaeghe A. The Gly16→Arg16 and Gln27→Glu27 polymorphisms of beta2-adrenergic receptor are associated with metabolic syndrome in men. J Clin Endocrinol Metab 2003, 88:4862-4866.
23. Lopes C., Dina C., Durand E., Froguel P. PAI-1 polymorphisms modulate phenotypes associated with the metabolic syndrome in obese and diabetic Caucasian population. Diabetologia 2003, 46:1284-1290.
24. Komurcu-Bayrak E., Onat A., Poda M., et al. The S447X variant of lipoprotein lipase gene is associated with metabolic syndrome and lipid levels among Turks. Clin Chim Acta 2007, 383:110-115.
25. Rooyen J.M., Pretorius P.J., Britz M., Huisman H.W., Schutte A.E., Towers G.W., et al. Genetic polymorphisms of beta2- and beta3-adrenergic receptor genes associated with characteristics of the metabolic syndrome in black South African Women. Exp Clin Endocrinol Diab 2008, 116:236-240.
26. Wong J., Nock N.L., Xu Z., et al. A polymorphism (D20S32e) close to the human melanocortin receptor 3 is associated with insulin resistance but not the metabolic syndrome. Diabetes Res Clin Pract 2008, 80:203-207.
27. Miyamoto Y., Morisaki H., Yamanaka I., et al. Association study of 11β-hydroxysteroid dehydrogenase type 1 gene polymorphisms and metabolic syndrome in urban Japanese cohort. Diabetes Res Clin Pract 2009, 85:132-138.
28. Invidia L., Salvioli S., Altilia S., et al. The frequency of Klotho KL-VS polymorphism in a large Italian population, from young subjects to centenarians, suggests the presence of specific time windows for its effect. Biogerontology 2010, 11:67-73.
29. Hanley A.J., Karter A.J., Festa A., et al. Factor analysis of metabolic syndrome using directly measured insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Diabetes 2002, 51:2642-2647.
30. Yang J., Matsukawa N., Rakugi H., et al. Upregulation of cAMP is a new functional signal pathway of Klotho in endothelial cells. Biochem Biophys Res Commun 2003, 301:424-429.
31. Zhang H., Li Y., Fan Y., et al. Klotho is a target gene of PPAR-gamma. Kidney Int 2008, 74:732-739.
32. Beaven S.W., Tontonoz P. Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia. Annu Rev Med 2006, 57:313-329.
33. Dominici F.P., Hauck S., Argentino D.P., Bartke A., Turyn D. Increased insulin sensitivity and upregulation of insulin receptor, insulin receptor substrate (IRS)-1 and IRS-2 in liver of Ames dwarf mice. J Endocrinol 2002, 173:81-94.
34. Freathy R.M., Weedon M.K., Melzer D., et al. The functional "KL-VS" variant of KLOTHO is not associated with type 2 diabetes in 5028 UK Caucasians. BMC Med Genet 2006, 7:51.